×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Value and Access – How Do We Strike a Balance between Both?
Session Chair(s)
Indranil Bagchi, PhD, MSc
Global Head, Pricing & Market Access
GSK, United States
Value and Access – How Do We Strike a Balance between Both?
Learning Objective : Participants will understand the payer perspective on Managed Access Agreements for high cost therapies, using examples from the NHS in England
Speaker(s)
Managed Access Agreements – A New Frontier in Germany?
Evert Jan van Lente, MS
AOK Bundesverband (Federal Insurer), Germany
Director EU-Affairs
![Edmund Jessop, DrMed](/_Images/member/Generic_Image_Missing-Profile.jpg)
Outcome Focussed Access Agreements: Payer Perspectives
Edmund Jessop, DrMed
National Health Service, United Kingdom
Medical adviser at NHS England
![Jan McKendrick, MSc](/_Images/member/Generic_Image_Missing-Profile.jpg)
Factors Leading to Difference between Regulatory and Market Access Decisions for Drugs in Six Cancers Internationally
Jan McKendrick, MSc
PRMA Consulting Ltd, United Kingdom
Senior Director
Have an account?